Evidence-Based Best Practices™

Real-World Issues in HIV Prevention & Treatment

The Critical Role of the Community Pharmacist

Jointly provided by Global Education Group and Integritas Communications.

This activity is supported by an independent educational grant from Gilead Sciences, Inc.

A satellite symposium held in conjunction with APhA2018.

In collaboration with The American Academy of HIV Medicine (AAHIVM).

Target Audience

The educational design of this activity addresses the needs of clinical pharmacists and other pharmacy staff involed in the care of patients with, or at risk of, human immunodeficiency virus (HIV) infection.

Educational Objectives

After completing this activity, the participant should be better able to:

  • Describe current HIV epidemiologic trends that inform universal HIV screening, identification of at-risk individuals, HIV prevention strategies, and HIV-care engagement strategies
  • Apply CDC guidelines for identification of individuals at risk for HIV acquisition and determination of preexposure prophylaxis (PrEP) eligibility
  • Demonstrate appropriate antiretroviral therapy (ART)-regimen selection at various stages of HIV treatment, including treatment initiation, treatment failure or viral resistance, and regimen simplification for long-term viral suppression
  • Provide patient education and support for optimized PrEP/ART effectiveness and safety

Program Agenda

  • 6:00 PM – Registration and Dinner
  • 6:30 PM – Welcome and Preactivity Assessment
  • 6:35 PM – The Critical Need for Pharmacy-Based Services Across the HIV Care Continuum
    Dan Scales, PharmD
  • 6:45 PM – Pharmacy-Based Primary HIV Prevention
    Elyse Tung, PharmD, BCACP
  • 7:15 PM – Pharmacists' Roles in Evolving HIV-Care Models: Consultation, Care, and Monitoring
    Jennifer Cocohoba, PharmD, BCPS, AAHIVP
  • 7:45 PM – Postactivity Assessment and Expert Q&A Session

Statement of Need/Program Overview

HIV incidence in the United States has recently declined, while advances in antiretroviral therapy (ART) have improved the longevity and quality of life of many people living with HIV.1,2 Nevertheless, opportunities to expand the capacity for HIV prevention and management abound. The Centers for Disease Control and Prevention has issued updated guidance on HIV preexposure prophylaxis (PrEP) for certain high-risk cohorts.3-5 Additionally, evidence-based guidelines related to HIV testing and the comprehensive care of HIV-infected patients are updated frequently.6 Given the increasingly busy environments of most health care settings, it is not surprising that providers are challenged to stay abreast of the latest best-practice recommendations. Moreover, the resulting gaps in HIV care are often exacerbated by limitations in access to health care. Accessibility and fundamental skill sets make pharmacists well-positioned to improve comprehensive and collaborative efforts for HIV prevention and management.6 In this Evidence-Based Best PracticesTM program, expert faculty will discuss the potential roles of pharmacists in testing for HIV infection, identifying patients who are eligible for PrEP, and selecting ART regimens for individuals living with HIV. The overall goal is to improve the ability of practicing pharmacists to engage in multidisciplinary and longitudinal HIV prevention and treatment strategies.


  1. CDC Fact Sheet. HIV Incidence: Estimated Annual Infections in the U.S., 2008-2014. Overall and by Transmission Route. Accessed January 26, 2018.
  2. CDC. Understanding the HIV Care Continuum. 2017. Accessed January 26, 2018.
  3. CDC. USPHS Preexposure Prophylaxis for the Prevention of HIV Infection in the United States—2014. Accessed January 26, 2017.
  4. Grant RM, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587-2599.
  5. Baeten J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399-410.
  6. US Department of Health and Human Services (DHHS). Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV. Updated 2018. 
  7. Schafer JJ, et al. ASHP guidelines on pharmacist involvement in HIV care. Am J Health Syst Pharm. 2016;73(7):468-494.

Continuing Pharmacy Education

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Global Educatoin Group designates this continuing education activity for 1.5 contact hour(s) (0.15 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number - 0530-9999-17-442-L01-P)

Activity Type: knowledge-based

For information about the accreditation of this program, please contaact Global at 303-395-1782 or

Disclosure of Conflicts of Interest

Global Education Group (Global) requires instructors, planners, managers, and other individuals and their spouses/life partners who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Americans with Disabilities Act

Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Katie Anderton prior to the live event at

Fee Information

There is no fee for this educational activity.

Register Now

Full Name *
Credentials *
You may receive up to 4 messages per live event. Terms & Privacy Policy can be found below.
Message and data rates may apply. Reply STOP to end or HELP for help.
Primary Specialty

By clicking Register, you accept our Privacy Policy.